BSE Live
Oct 30, 16:01Prev. Close
1339.95
Open Price
1345.05
Bid Price (Qty.)
1335.10 (1)
Offer Price (Qty.)
1340.00 (14)
NSE Live
Oct 30, 15:56Prev. Close
1339.60
Open Price
1340.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
| Key Financial Ratios of Emcure Pharmaceuticals (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | 16.95 | 8.89 | 8.85 | 24.71 | 23.25 | |
| Diluted EPS (Rs.) | 16.95 | 8.89 | 8.85 | 24.71 | 23.25 | |
| Cash EPS (Rs.) | 28.61 | 20.19 | 18.72 | 33.87 | 31.89 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 159.61 | 106.82 | 101.84 | 94.69 | 127.27 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 159.61 | 106.82 | 101.84 | 94.69 | 127.27 | |
| Dividend / Share(Rs.) | 3.00 | 3.00 | 2.00 | 1.00 | 1.00 | |
| Revenue from Operations/Share (Rs.) | 231.26 | 193.08 | 171.80 | 187.29 | 174.38 | |
| PBDIT/Share (Rs.) | 40.41 | 32.03 | 31.18 | 51.28 | 47.29 | |
| PBIT/Share (Rs.) | 28.53 | 20.72 | 21.31 | 42.11 | 38.65 | |
| PBT/Share (Rs.) | 22.57 | 11.04 | 11.74 | 34.08 | 30.82 | |
| Net Profit/Share (Rs.) | 16.74 | 8.88 | 8.85 | 24.71 | 23.25 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | 17.47 | 16.58 | 18.14 | 27.37 | 27.12 | |
| PBIT Margin (%) | 12.33 | 10.73 | 12.40 | 22.48 | 22.16 | |
| PBT Margin (%) | 9.76 | 5.71 | 6.83 | 18.19 | 17.67 | |
| Net Profit Margin (%) | 7.23 | 4.59 | 5.15 | 13.19 | 13.33 | |
| Return on Networth / Equity (%) | 10.48 | 8.31 | 8.69 | 26.09 | 18.26 | |
| Return on Capital Employed (%) | 14.62 | 14.28 | 14.70 | 31.87 | 22.74 | |
| Return on Assets (%) | 5.85 | 3.38 | 3.46 | 10.33 | 8.64 | |
| Total Debt/Equity (X) | 0.22 | 0.73 | 0.91 | 0.92 | 0.57 | |
| Asset Turnover Ratio (%) | 0.86 | 0.75 | 0.70 | 0.74 | 0.72 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 1.43 | 1.00 | 1.07 | 1.10 | 1.24 | |
| Quick Ratio (X) | 0.83 | 0.64 | 0.72 | 0.73 | 0.89 | |
| Inventory Turnover Ratio (X) | 4.85 | 1.47 | 1.30 | 1.59 | 1.97 | |
| Dividend Payout Ratio (NP) (%) | 0.00 | 33.73 | 22.59 | 12.14 | 4.30 | |
| Dividend Payout Ratio (CP) (%) | 0.00 | 14.83 | 10.68 | 8.85 | 3.13 | |
| Earnings Retention Ratio (%) | 0.00 | 66.27 | 77.41 | 87.86 | 95.70 | |
| Cash Earnings Retention Ratio (%) | 0.00 | 85.17 | 89.32 | 91.15 | 96.87 | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | 20,969.76 | 0.00 | 0.00 | 0.00 | 0.00 | |
| EV/Net Operating Revenue (X) | 4.79 | 0.00 | 0.00 | 0.00 | 0.00 | |
| EV/EBITDA (X) | 27.39 | 0.00 | 0.00 | 0.00 | 0.00 | |
| MarketCap/Net Operating Revenue (X) | 4.64 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Retention Ratios (%) | 0.00 | 66.26 | 77.40 | 87.85 | 95.69 | |
| Price/BV (X) | 6.72 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Price/Net Operating Revenue | 4.64 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Earnings Yield | 0.02 | 0.00 | 0.00 | 0.00 | 0.00 | 
07.08.2025
Emcure Pharmace Standalone June 2025 Net Sales at Rs 1,096.57 crore, up 13.01% Y-o-Y
17.07.2025
10.07.2025
07.07.2025
07.08.2025
Emcure Pharmace Standalone June 2025 Net Sales at Rs 1,096.57 crore, up 13.01% Y-o-Y
27.05.2025
Emcure Pharmace Consolidated March 2025 Net Sales at Rs 2,116.25 crore, up 19.47% Y-o-Y
23.05.2025
Emcure Pharmace Standalone March 2025 Net Sales at Rs 1,278.19 crore, up 41.62% Y-o-Y
12.02.2025
Emcure Pharmace Standalone December 2024 Net Sales at Rs 1,028.81 crore, up 18.23% Y-o-Y